KyungDong Pharm CEO and Chairman Ryu Deok-hee retired on June 30. As a result, the current CEO and Vice Chairman Ryu Ki-seong will assume sole responsibility as CEO of KyungDong Pharm.

 

KyungDong Pharm's founder, Chairman Ryu Deok-hee, founded KyungDong Pharm's predecessor company, 'Yoil Trading Company', in September 1975 and changed its name to 'KyungDong Pharm' in 1976 the following year, leading the company for 46 years. KyungDong Pharm, which started as a manufacturer specializing in therapeutics, developed and produced synthesis methods and new formulations of many medicines that used to be imported, using domestic technology, resulting in a huge amount of import substitution.

 

Chairman Deok-hee Ryu’s philosophy of management through sharing underpinned the company’s growth into a mid-sized pharmaceutical business. Cumulative donations since its early years have reached approximately KRW 36.1 billion. He has also contributed to the pharmaceutical industry through roles including chairman of the Korea Pharmaceutical Cooperative, vice chairman of the Korea Federation of Small Business, and chairman of the Korea Pharmaceutical Manufacturers Association. Although he is stepping back from day-to-day management, the company plans to appoint him honorary chairman and continue carrying forward its founding spirit.

 

Meanwhile, CEO Ryu Ki-seong joined KyungDong Pharm in 2006 and served as the head of the Management Strategy Division, managing tasks such as development, marketing, and import and export. He took office as CEO in 2011 and accumulated experience in all fields, including establishing drug development and sales and growth strategies and expanding his business area to head of the production division and R&D center.

 

An official from KyungDong Pharm said, “Even after his retirement, as honorary chairman, he will continue to take an interest in the overall management of the company and actively provide advice as needed.”